Neuromuscular blocking drugs in pediatric anesthesia.
There are differences between pediatric patients and adults in the responses to neuromuscular blockers. The results of new studies of neuromuscular blockers in pediatric patients are generally consistent with earlier studies in the type of age-related differences documented. Surprising new results are the side effects, including anaphylaxis, that have been observed, and studied directly, in pediatric patients. Continued evaluation of these drugs in pediatric patients will provide better information regarding the variability of the effects of neuromuscular blockers in healthy and diseased infants and children.
Brandom
Barbara W
BW
Department of Anesthesiology, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Fine
Gavin F
GF
D000375:Aging / Q000502:physiology; D000758:Anesthesia; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007273:Injections, Intramuscular; D009466:Neuromuscular Blocking Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000493:pharmacokinetics / Q000494:pharmacology
D009466:Neuromuscular Blocking Agents